Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of Stroke

This study has been completed.
Zhejiang Otsuka Pharmaceutical Co., Ltd.
Information provided by:
Otsuka Beijing Research Institute Identifier:
First received: September 12, 2005
Last updated: March 15, 2006
Last verified: March 2006